Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease

S. Burge

Source: Eur Respir Mon; 2006: 38: 281–295
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Burge. Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease. Eur Respir Mon; 2006: 38: 281–295

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008


The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics
Source: Eur Respir J 2003; 21: 95-10
Year: 2003



Quality of life in patients with chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=375
Year: 2006

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT(R) trial
Source: Eur Respir J 2010; 36: 65-73
Year: 2010



Does rapid decline predict poor prognosis?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007


Effect of inhaled bronchodilator therapy on the bacterioexcretion and on the quality of life (LQ) of pulmonary TB patients with concomitant lung obstructive syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 217-224
Year: 2002



The effect of tiotropium on exacerbations and airflow in patients with COPD
Source: Eur Respir J 2006; 27: 547-555
Year: 2006



Tiotropium as essential maintenance therapy in COPD
Source: Eur Respir Rev 2006; 15: 51-57
Year: 2006



Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Source: Eur Respir J 2002; 19: 209-216
Year: 2002



Where current pharmacological therapies fall short in COPD: symptom control is not enough
Source: Eur Respir Rev 2007; 16: 98-104
Year: 2007



Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006


Medication use in COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007




Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


Evidence for the onset of COPD in childhood, and the role of genetics
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005

Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Year: 2008


Long-term efficacy of repeated pulmonary rehabilitation programs (PRP) in chronic airway obstruction (CAO)
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014